Physician profile
Scott Charles Epperly
NPI 1356798938
$3,549.32
in general payments reported to CMS, 2019-2025
7 companies · $2,702 in 2025
The $2,702 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.28 · 2023: $20.39 · 2024: $803 · 2025: $2,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,624 · Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,624.11 |
| Food and Beverage | $900.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,392.96 | 2025 | |
| Wildwood Medical LLC | $1,020.22 | 2025 | |
| Steelhead Surgical INC | $726.99 | 2024 | |
| Amgen INC. | $330.50 | 2023-2025 | Evenity, Prolia, Prolia |
| Mindray Ds USA, INC. | $30.83 | 2024 | Te7 Max, Te X |
| Zimmer Biomet Holdings, INC. | $24.28 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.54 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Epperly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.